Pages that link to "Q34465829"
Jump to navigation
Jump to search
The following pages link to Can patents deter innovation? The anticommons in biomedical research (Q34465829):
Displaying 50 items.
- Innovation and access to medicines for neglected populations: could a treaty address a broken pharmaceutical R&D system? (Q21144610) (← links)
- Share and share alike: deciding how to distribute the scientific and social benefits of genomic data (Q24550673) (← links)
- Do we need to put society first? The potential for tragedy in antimicrobial resistance (Q25255615) (← links)
- Innovation in biomedicine: can stem cell research lead the way to affordability? (Q25256306) (← links)
- Beyond access to medicines: Eliciting high-income country support for a new global health research and development paradigm (Q27026462) (← links)
- Determinants and public policy implications of academic-industry knowledge transfer in life sciences: a review and a conceptual framework (Q27890371) (← links)
- Intellectual property rights and innovation: Evidence from the human genome (Q27985945) (← links)
- Open Genetic Code: on open source in the life sciences (Q28269896) (← links)
- From "publish or perish" to "patent and prosper" (Q28301488) (← links)
- Multi-material additive and subtractive prosumer digital fabrication with a free and open-source convertible delta RepRap 3-D printer (Q28315787) (← links)
- Gene characterization index: assessing the depth of gene annotation (Q28471960) (← links)
- Open access target validation is a more efficient way to accelerate drug discovery (Q28547855) (← links)
- The science commons in health research: structure, function, and value (Q28597890) (← links)
- Biobanks in Oral Health: Promises and Implications of Post-Neoliberal Science and Innovation (Q28601422) (← links)
- The use of agrobiodiversity for plant improvement and the intellectual property paradigm: institutional fit and legal tools for mass selection, conventional and molecular plant breeding (Q28607339) (← links)
- Technology Commercialization Effects on the Conduct of Research in Higher Education (Q28731278) (← links)
- Myriad Genetics: In the eye of the policy storm (Q28742896) (← links)
- A response to Rome: lessons from pre- and post-publication data-sharing in the C. elegans research community (Q28743580) (← links)
- Protein Structure Initiative Material Repository: an open shared public resource of structural genomics plasmids for the biological community (Q28749249) (← links)
- Patents in genomics and human genetics (Q28749392) (← links)
- One step forward, one step sideways? Expanding research capacity for neglected diseases (Q28749681) (← links)
- Proprietary science, open science and the role of patent disclosure: the case of zinc-finger proteins (Q28751821) (← links)
- Evidence and anecdotes: an analysis of human gene patenting controversies (Q28752430) (← links)
- Patents and innovation in cancer therapeutics: lessons from CellPro (Q28752638) (← links)
- Commercialization of basic research from within the university and return of value to the public (Q28755240) (← links)
- Prima facie reasons to question enclosed intellectual property regimes and favor open-source regimes for germplasm. (Q30376961) (← links)
- When Copyright Law and Science Collide: Empowering Digitally Integrated Research Methods on a Global Scale (Q30392081) (← links)
- Biological diversity in the patent system (Q30392829) (← links)
- Assessing research impact in academic clinical medicine: a study using Research Excellence Framework pilot impact indicators (Q30394353) (← links)
- The CREATE Act: increasing costs associated with the biotech industry? (Q30440979) (← links)
- Changing patent strategies: what will they mean for the industry? (Q30444220) (← links)
- Empirical analysis of major stem cell patent cases: the role of universities (Q30450579) (← links)
- Neuroscience data and tool sharing: a legal and policy framework for neuroinformatics (Q30482640) (← links)
- An intellectual property sharing initiative in agricultural biotechnology: development of broadly accessible technologies for plant transformation (Q30485273) (← links)
- Open Access Could Transform Drug Discovery: A Case Study of JQ1. (Q30488815) (← links)
- From Gutenberg to Open Science: An Unfulfilled Odyssey (Q30490232) (← links)
- Synthetic biology: caught between property rights, the public domain, and the commons (Q33278090) (← links)
- Is Bayh-Dole good for developing countries? Lessons from the US experience (Q33380408) (← links)
- Effects of research tool patents on biotechnology innovation in a developing country: a case study of South Korea (Q33422168) (← links)
- Are patents impeding medical care and innovation? (Q33522199) (← links)
- Patents, innovation, and privatization: Commentary on: "Data management in academic settings: an intellectual property perspective". (Q33706373) (← links)
- The impact of patents on the development of genome-based clinical diagnostics: an analysis of case studies (Q33865988) (← links)
- Patent data mining: a tool for accelerating HIV vaccine innovation (Q33874576) (← links)
- Patenting of genetic material: are the benefits to society being realized? (Q33895413) (← links)
- The contract research organization and the commercialization of scientific research (Q33991605) (← links)
- Nucleic acid vaccines: research tool or commercial reality (Q34023547) (← links)
- New approaches to rewarding pharmaceutical innovation (Q34154435) (← links)
- DNA patents and scientific discovery and innovation: assessing benefits and risks (Q34159616) (← links)
- Translating personalized medicine using new genetic technologies in clinical practice: the ethical issues (Q34159801) (← links)
- Patenting human genetic material: refocusing the debate (Q34185450) (← links)